Education
2025 - 2027
NYU Stern
Executive MBA
In coming class... more to come.
2017 - 2019
Northwestern University
Master of Biotechnology
Key Classes:
- Critical Thinking and Communication
- Leadership Perspectives
- Biomedical Marketing
- Medical Technology Financialisation and Commercialisation
- Bioprocessing Engineering
2014 - 2017
University of Nottingham
BSc Hons Biotechnology
Key Classes:
- Technology Entrepeurnership in Practise
- Environmental Biotechnology
- Molecular Nutrition
- Genetic Improvement of Crop Plants
- Applied Bioethics
Expertise
- Neuroscience CI and SI including Alzheimer's, Multiple Sclerosis, and Friedreich Ataxia
- Digital Health SI with a focus on digital diagnostics
CI - competitive intelligence
SI - strategic intelligence
Experience
Oct 2022 - Present
Deallus
Senior Consultant
- 6-month secondment as Competitor Intelligence Director for a large player in the global HIV market
- Led the development of a deep dive and workshop into the EU5 general myasthenia gravis landscape for the commercial launch of a novel therapy
Jan 2022 - Jul 2024
Deallus
Innovation Manager
- Led the development of innovative software that is driving efficiencies within the company (e.g. one tool reduces the time spent monitoring a therapeutic area and set of competitors by approx. 20%)
- Led the internal roll-out of the innovative management platforms and CI tools with multiple company-wide lunch and learns, drop-in sessions, as well as 1:1's
Jul 2021 - Sep 2022
Deallus
Consultant
- Led the development and maintenance of several deep dives for an established botulinum toxin in new indications
- Conducted an extensive evaluation of emerging technologies and care strategies for multiple sclerosis
Feb 2021 - Jul 2021
Deallus
Senior Associate
- Facilitated in the development of an innovative management platform utilised internally by consultants and externally with clients
- Advised the commercial strategy and competitor landscape for a novel COVID-19 vaccine during its global launch
Oct 2019 - Feb 2021
Deallus
Associate
- Participated in an internal primary research pilot program to generate a more sustainable source network
- Helped in the on-boarding and mentorship of new members across my five projects
Jan 2019 – Jun 2019
Northwestern University: Innovation and New Ventures
Innovation Analyst
- Innovation Analyst as part of Northwestern Universities Innovation and New Ventures (INVO) Practicum program
- I conducted assessments of new University technologies based on intellectual property, marketability, and its ability to be commercialised
- Developed Northwestern University's therapeutic database (all internally developed biologics, small molecules, and medical devices) for external investors and partners
Sep 2018 – Dec 2018
Northwestern University
Graduate Teaching Assistant
- Teaching assistant for the graduate level class, Technology Commercialisation, in which students take a small molecule or biologic that is currently in Phase I or II and develop a commercialisation strategy to get it to market
Jul 2018 - Sep 2018
Affinity Medical Ventures
Business Consultant
- Facilitated in the licensing of novel technologies from University technology transfer offices
- Developed an extensive product profile through in-depth analysis of direct and indirect competitors, the market landscape and risks from future technologies
Jun 2018 - Sep 2018
Avivo BioOptics
Business Consultant
- Worked with a contract research organisation for preclinical trials of a colorectal cancer diagnostic device
- Helped develop an investor pitch deck for series A fundraising
Jan 2018 - Mar 2018
BlacTie
Business Consultant
- Designed an extensive marketing strategy for an organs-on-a-chip device
- Developed an investor deck addressing effective strategies, business plans, and valuation models for an early-stage medical device in the 3D cell culture market
Nov 2017 – Jun 2019
Northwestern University
Graduate Researcher
- Over the course of my Masters degree I conducted three research projects involving the analysis of recall events for blood, tissue and drug product
- Developed computational models in ArcGIS, as well as, performed statistical analysis using JMP and Tableau to determine the data significance
Aug 2016 - Apr 2017
University of Nottingham
Undergraduate Researcher
- Conducted experiments to determine the role of anthers and pollen in Fusarium head blight caused by Fusarium Graminearum and Fusarium Culmorum in barley
- Communicated research data effectively in both written reports and oral presentations to a group of professors and other students
Research
A cross-sectional study of prevalence, distribution, cause, and impact of blood product recalls in the United States
Key Points:
• Blood product recalls are highly prevalent in certain geographic regions, and distribution patterns vary between product types
• Inadequate donor screening, compromised sterility, and contamination contribute most to the burden of blood products recalls
Published in Blood Advances
CARe To Understand What Will Shape CAR T’s Future?
Key Points:
• COVID-19 is slowing CAR Ts’ progress, starting with delaying the FDA approval process of BMS’ Liso-cel by 2 months, due to a hindered inspection process, while also impacting trial development for new products, and revenue growth for existing ones
• Commercialisation success of CAR Ts remains impacted by its reimbursement, pricing and market access challenges in both the US, EU and elsewhere, where new pricing and payment models are being ‘tested’
White Paper for Deallus Consulting
From bed-side to web-side: the future for telehealth and neuroscience in the US
Key Points:
• Led the research into how Covid-19 has accelerated the uptake of virtual services within neuroscience, which has set in motion a reimagining of future healthcare pathways
• We examine the patient/provider shift in utilising telehealth, recent industry investment, regulatory/reimbursement adoption, as well as how key federal and state laws are enabling telehealth
White Paper for Deallus Consulting
